Physician profile
Thomas Gould
NPI 1730292772
$9,078.12
in general payments reported to CMS, 2019-2025
14 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,275 · 2020: $2,523 · 2021: $140 · 2022: $951 · 2024: $67.86 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,079.65 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.21 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $164.99 | 2019-2020 | |
| Allergan, INC. | $131.13 | 2019 | |
| Kite Pharma, INC. | $121.33 | 2025 | |
| Nestle Healthcare Nutrition INC. | $101.17 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.03 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $67.25 | 2019 | |
| Exact Sciences Corporation | $42.71 | 2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $20.31 | 2019 | |
| Gilead Sciences, INC. | $19.62 | 2020 | |
| Janssen Biotech, INC. | $17.72 | 2019 | |
| Braintree Laboratories, INC. | $16.20 | 2019 | |
| Shionogi INC | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.